Search Results - "Oving, I.M."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1823P The impact of baseline PSMA PET/CT vs. CT on outcomes of Radium-223 therapy in mCRPC patients

    1823P The impact of baseline PSMA PET/CT vs. CT on outcomes of Radium-223 therapy in mCRPC patients by Bosch, D., van der Velden, K., Oving, I.M., Wyndaele, D.N.J., Weijs, L.E., van Schelven, D.W., Oyen, W.J.G., Te Beek, E.T., Somford, D.M., Nagarajah, J., Hermsen, R., Mehra, N., Gerritsen, W.R., van der Doelen, M.J., van Oort, I.M.

    Published in Annals of oncology (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    1818P Final results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)

    1818P Final results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC) by van der Zande, K., van der Noort, V., Busard, M., Hamberg, P., Ras - van Spijk, S., de Feijter, J., Dezentje, V., Tascilar, M., Houtsma, D., Beeker, A., van den Berg, P., ten Oever, D., Oving, I.M., Zwart, W., Bergman, A.M.

    Published in Annals of oncology (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: